Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Cancer Cell

Volumn 33, Issue 4, 2018, Pages 676-689.e3

  Taylor, Alison M ^a,b,c   Shih, Juliann ^b   Ha, Gavin ^a,b,c   Gao, Galen F ^b,g   Zhang, Xiaoyang ^a,b,c   Berger, Ashton C ^b   Schumacher, Steven E ^a,b   Wang, Chen ^d   Hu, Hai ^e   Liu, Jianfang ^e   Lazar, Alexander J ^f,g   Caesar Johnson, Samantha J ^g   Demchok, John A ^g   Felau, Ina ^g   Kasapi, Melpomeni ^g   Ferguson, Martin L ^g   Hutter, Carolyn M ^g   Sofia, Heidi J ^g   Tarnuzzer, Roy ^g   Wang, Zhining ^g   Yang, Liming ^g   Zenklusen, Jean C ^g   Beroukhim, Rameen ^a,b,c   Cherniack, Andrew D ^a,b,c   Meyerson, Matthew ^a,b,c   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Mayo Clinic College of Medicine   (United States)

^e Chan Soon Shiong Institute of Molecular Medicine   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g Julia)

Author keywords

aneuploidy; cancer genomics; genome engineering; lung squamous cell carcinoma

Indexed keywords

ANEUPLOIDY; ARTICLE; CELL PROLIFERATION; CHROMOSOME 3P; CHROMOSOME ARM; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CONTROLLED STUDY; GENETIC ENGINEERING; GENOME; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MALIGNANT NEOPLASM; PHENOTYPE; PRIORITY JOURNAL; CELL CYCLE; CHROMOSOME 3; CHROMOSOME ABERRATION; GENETIC DATABASE; GENETICS; GENOMICS; MUTATION RATE; PROCEDURES; SQUAMOUS CELL CARCINOMA;

PROTEIN P53; TP53 PROTEIN, HUMAN;

ANEUPLOIDY; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; DATABASES, GENETIC; GENOMICS; HUMANS; MUTATION RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85044906084     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2018.03.007     Document Type: Article

References (55)

1. Adalsteinsson, V.A., Ha, G., Freeman, S.S., Choudhury, A.D., Stover, D.G., Parsons, H.A., Gydush, G., Reed, S.C., Rotem, D., Rhoades, J., et al. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat. Commun., 8, 2017, 1324.
2. Aran, D., Hu, Z., Butte, A.J., xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol., 18, 2017, 220.
3. Barkauskas, C.E., Chung, M.I., Fioret, B., Gao, X., Katsura, H., Hogan, B.L., Lung organoids: current uses and future promise. Development 144 (2017), 986–997.
4. Bass, A.J., Watanabe, H., Mermel, C.H., Yu, S., Perner, S., Verhaak, R.G., Kim, S.Y., Wardwell, L., Tamayo, P., Gat-Viks, I., et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat. Genet. 41 (2009), 1238–1242.
5. Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J.C., Huang, J.H., Alexander, S., et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. USA 104 (2007), 20007–20012.
6. Beroukhim, R., Mermel, C.H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J.S., Dobson, J., Urashima, M., et al. The landscape of somatic copy-number alteration across human cancers. Nature 463 (2010), 899–905.
7. Bonney, M.E., Moriya, H., Amon, A., Aneuploid proliferation defects in yeast are not driven by copy number changes of a few dosage-sensitive genes. Genes Dev. 29 (2015), 898–903.
8. Brennan, C.W., Verhaak, R.G., McKenna, A., Campos, B., Noushmehr, H., Salama, S.R., Zheng, S., Chakravarty, D., Sanborn, J.Z., Berman, S.H., et al. The somatic genomic landscape of glioblastoma. Cell 155 (2013), 462–477.
9. Buccitelli, C., Salgueiro, L., Rowald, K., Sotillo, R., Mardin, B.R., Korbel, J.O., Pan-cancer analysis distinguishes transcriptional changes of aneuploidy from proliferation. Genome Res. 27 (2017), 501–511.
10. Cai, Y., Crowther, J., Pastor, T., Abbasi Asbagh, L., Baietti, M.F., De Troyer, M., Vazquez, I., Talebi, A., Renzi, F., Dehairs, J., et al. Loss of chromosome 8p governs tumor progression and drug response by altering lipid metabolism. Cancer Cell 29 (2016), 751–766.
11. Cairncross, G., Wang, M., Shaw, E., Jenkins, R., Brachman, D., Buckner, J., Fink, K., Souhami, L., Laperriere, N., Curran, W., et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J. Clin. Oncol. 31 (2013), 337–343.
12. Campbell, J.D., Alexandrov, A., Kim, J., Wala, J., Berger, A.H., Pedamallu, C.S., Shukla, S.A., Guo, G., Brooks, A.N., Murray, B.A., et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat. Genet. 48 (2016), 607–616.
13. Cancer Genome Atlas Research Network, Kandoth, C., Schultz, N., Cherniack, A.D., Akbani, R., Liu, Y., Shen, H., Robertson, A.G., Pashtan, I., Shen, R., et al. Integrated genomic characterization of endometrial carcinoma. Nature 497 (2013), 67–73.
14. Cancer Genome Atlas Research Network, Brat, D.J., Verhaak, R.G., Aldape, K.D., Yung, W.K., Salama, S.R., Cooper, L.A., Rheinbay, E., Miller, C.R., Vitucci, M., et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372 (2015), 2481–2498.
15. Carter, S.L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P.W., Onofrio, R.C., Winckler, W., Weir, B.A., et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30 (2012), 413–421.
16. Carter, S.L., Eklund, A.C., Kohane, I.S., Harris, L.N., Szallasi, Z., A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38 (2006), 1043–1048.
17. Ciriello, G., Miller, M.L., Aksoy, B.A., Senbabaoglu, Y., Schultz, N., Sander, C., Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45 (2013), 1127–1133.
18. Davoli, T., Uno, H., Wooten, E.C., Elledge, S.J., Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science, 355, 2017, 10.1126/science.aaf8399.
19. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., Gingeras, T.R., STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29 (2013), 15–21.
20. Ellrott, K., Bailey, M.H., Saksena, G., Covington, K.R., Kandoth, C., Stewart, C., Hess, J., Ma, S., Chiotti, K.E., McLellan, M., et al. Scalable open scienceapproach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Systems 6 (2018), 271–281.
21. Hagerstrand, D., Tong, A., Schumacher, S.E., Ilic, N., Shen, R.R., Cheung, H.W., Vazquez, F., Shrestha, Y., Kim, S.Y., Giacomelli, A.O., et al. Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers. Cancer Discov. 3 (2013), 1044–1057.
22. Hoadley, K.A., Yau, C., Wolf, D.M., Cherniack, A.D., Tamborero, D., Ng, S., Leiserson, M.D.M., Niu, B., McLellan, M.D., Uzunangelov, V., et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158 (2014), 929–944.
23. Holland, A.J., Cleveland, D.W., Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat. Rev. Mol. Cell Biol. 10 (2009), 478–487.
24. Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V., Li, Y., Fine, E.J., Wu, X., Shalem, O., et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31 (2013), 827–832.
25. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D.D., Minna, J.D., Gazdar, A.F., Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273 (1995), 558–563.
26. Lai, D., Ha, G., Shah, S., HMMcopy: Copy Number Prediction with Correction for GC and Mappability Bias for HTS Data. R Package Version 1.18.0. 2016 https://rdrr.io/bioc/HMMcopy/.
27. Larsson, L.G., Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin. Cancer Biol. 21 (2011), 367–376.
28. Li, B., Dewey, C.N., RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics, 12, 2011, 323.
29. Liu, Y., Chen, C., Xu, Z., Scuoppo, C., Rillahan, C.D., Gao, J., Spitzer, B., Bosbach, B., Kastenhuber, E.R., Baslan, T., et al. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Nature 531 (2016), 471–475.
30. Lundberg, A.S., Randell, S.H., Stewart, S.A., Elenbaas, B., Hartwell, K.A., Brooks, M.W., Fleming, M.D., Olsen, J.C., Miller, S.W., Weinberg, R.A., et al. Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene 21 (2002), 4577–4586.
31. Mali, P., Esvelt, K.M., Church, G.M., Cas9 as a versatile tool for engineering biology. Nat. Methods 10 (2013), 957–963.
32. Mitelman, F., Recurrent chromosome aberrations in cancer. Mutat. Res. 462 (2000), 247–253.
33. Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Prettenhofer, P., Weiss, R., Dubourg, V., et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12 (2011), 2825–2830.
34. Ried, T., Hu, Y., Difilippantonio, M.J., Ghadimi, B.M., Grade, M., Camps, J., The consequences of chromosomal aneuploidy on the transcriptome of cancer cells. Biochim. Biophys. Acta 1819 (2012), 784–793.
35. Rizvi, N.A., Hellmann, M.D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J.J., Lee, W., Yuan, J., Wong, P., Ho, T.S., et al. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348 (2015), 124–128.
36. Robinson, M.D., McCarthy, D.J., Smyth, G.K., edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26 (2010), 139–140.
37. Santaguida, S., Richardson, A., Iyer, D.R., M'Saad, O., Zasadil, L., Knouse, K.A., Wong, Y.L., Rhind, N., Desai, A., Amon, A., Chromosome mis-segregation generates cell-cycle-arrested cells with complex karyotypes that are eliminated by the immune system. Dev. Cell 41 (2017), 638–651.e5.
38. Senovilla, L., Vitale, I., Martins, I., Tailler, M., Pailleret, C., Michaud, M., Galluzzi, L., Adjemian, S., Kepp, O., Niso-Santano, M., et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 337 (2012), 1678–1684.
39. Sheltzer, J.M., Blank, H.M., Pfau, S.J., Tange, Y., George, B.M., Humpton, T.J., Brito, I.L., Hiraoka, Y., Niwa, O., Amon, A., Aneuploidy drives genomic instability in yeast. Science 333 (2011), 1026–1030.
40. Sheltzer, J.M., Ko, J.H., Replogle, J.M., Habibe Burgos, N.C., Chung, E.S., Meehl, C.M., Sayles, N.M., Passerini, V., Storchova, Z., Amon, A., Single-chromosome gains commonly function as tumor suppressors. Cancer Cell 31 (2017), 240–255.
41. Stingele, S., Stoehr, G., Peplowska, K., Cox, J., Mann, M., Storchova, Z., Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol. Syst. Biol., 8, 2012, 608.
42. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005), 15545–15550.
43. Sundaresan, V., Ganly, P., Hasleton, P., Rudd, R., Sinha, G., Bleehen, N.M., Rabbitts, P., p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7 (1992), 1989–1997.
44. Tang, Y.C., Amon, A., Gene copy-number alterations: a cost-benefit analysis. Cell 152 (2013), 394–405.
45. Taylor-Weiner, A., Zack, T., O'Donnell, E., Guerriero, J.L., Bernard, B., Reddy, A., Han, G.C., AlDubayan, S., Amin-Mansour, A., Schumacher, S.E., et al. Genomic evolution and chemoresistance in germ-cell tumours. Nature 540 (2016), 114–118.
46. Thorsson, V., Gibbs, D.L., Brown, S.D., Wolf, D., Bortone, D.S., Ou Yang, T.-H., Porta Pardo, E., Gao, G., Eddy, J.A., Plaisier, C.L., et al. The ilmmune landscape of cancer. Immunity, 2018, 10.1016/j.immuni.2018.03.023.
47. Topalian, S.L., Taube, J.M., Anders, R.A., Pardoll, D.M., Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat. Rev. Cancer 16 (2016), 275–287.
48. Torres, E.M., Sokolsky, T., Tucker, C.M., Chan, L.Y., Boselli, M., Dunham, M.J., Amon, A., Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317 (2007), 916–924.
49. Uno, N., Hiramatsu, K., Uno, K., Komoto, S., Kazuki, Y., Oshimura, M., CRISPR/Cas9-induced transgene insertion and telomere-associated truncation of a single human chromosome for chromosome engineering in CHO and A9 cells. Sci. Rep., 7, 2017, 12739.
50. Weaver, B.A., Cleveland, D.W., Does aneuploidy cause cancer?. Curr. Opin. Cell Biol. 18 (2006), 658–667.
51. Williams, B.R., Prabhu, V.R., Hunter, K.E., Glazier, C.M., Whittaker, C.A., Housman, D.E., Amon, A., Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322 (2008), 703–709.
52. Wistuba, I.I., Behrens, C., Virmani, A.K., Mele, G., Milchgrub, S., Girard, L., Fondon, J.W. 3rd, Garner, H.R., McKay, B., Latif, F., et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 60 (2000), 1949–1960.
53. Xue, W., Kitzing, T., Roessler, S., Zuber, J., Krasnitz, A., Schultz, N., Revill, K., Weissmueller, S., Rappaport, A.R., Simon, J., et al. A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proc. Natl. Acad. Sci. USA 109 (2012), 8212–8217.
54. Zabarovsky, E.R., Lerman, M.I., Minna, J.D., Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21 (2002), 6915–6935.
55. Zack, T.I., Schumacher, S.E., Carter, S.L., Cherniack, A.D., Saksena, G., Tabak, B., Lawrence, M.S., Zhang, C.Z., Wala, J., Mermel, C.H., et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45 (2013), 1134–1140.